Facebook Linkedin RSS Twitter Youtube
Home 2024

RNA virus

A Solution to Industry’s Lentiviral Vector Challenge?
Bioprocessing

A Solution to Industry’s Lentiviral Vector Challenge?

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Mitigating Risks in Oligonucleotide Therapeutic Development
Sponsored

Mitigating Risks in Oligonucleotide Therapeutic Development

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio for $600 Million
Bioprocessing

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio for $600 Million

Severe COVID-19 Lung Disease Linked to Ferroptosis
Infectious Diseases

Severe COVID-19 Lung Disease Linked to Ferroptosis

Zika and Dengue Infections Differentiated Using Epitope Surrogate Technology
Infectious Diseases

Zika and Dengue Infections Differentiated Using Epitope Surrogate Technology

Universal Flu Vaccine May No Longer Be a Long Shot
Drug Discovery

Universal Flu Vaccine May No Longer Be a Long Shot

Asimov Expands Lentivirus Production Portfolio with Cell Line Development Service
Bioprocessing

Asimov Expands Lentivirus Production Portfolio with Cell Line Development Service

In Vivo Gene Editing Grants Access to Medical Treasures
Genome Editing

In Vivo Gene Editing Grants Access to Medical Treasures

Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
Drug Discovery

Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses

123...164Page 1 of 164
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.